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ABSTRACT 
 
Background: Influenza A virus is a common human pathogen that has caused serious respiratory illness and death 
over the past century. In April 2009, WHO declared pandemic influenza A H1N1 public health emergency of 
international concern. India is reeling under the worst H1N1 influenza outbreak with over 18,000 affected cases and 
over 1000 deaths by the year 2015. Methods: The present study was conducted to find the clinical and 
epidemiological profile of H1N1 influenza A cases and a real time RT-PCR was standardized and evaluated for the 
detection of H1N1 influenza A virus in suspected cases admitted in a tertiary care hospital of northern India. 
Results: Of the total 184 clinical samples tested, 48(26.0%) samples were found to be positive for influenza A 
H1N1 virus by real time RT-PCR. The highest percentage of cases was in the age group of 40-55 years followed by 
the 20-40 years. The main clinical symptoms were fever(95.8%), breathlessness(77.0%) , cough(68.7%) and sore 
throat (56.2%).The mortality rate of cases admitted with H1N1 infection was 52.0%. Conclusion: The mutational 
behavior of H1N1 has been a major future challenge in the part of pharmacotherapy. Rapid and sensitive diagnostic 
methods like real time RT-PCR increase the capability to detect, understand and assess new viruses for pandemic 
risk and to track their international spread. 
Key words: Influenza A H1N1, Real Time RT-PCR. 
Introduction 
Influenza virus is a common human pathogen that has 
caused serious respiratory illness and death over the 
past century. It always had potential to cause 
widespread pandemics whenever a new type of 
Influenza strain appeared in the human population 
[1].A new strain of Influenza A (H1N1) virus was first 
identified in humans in Mexico and the United States 
(US) in 2009 and has since spread worldwide (WHO, 
2009). The World Health Organization (WHO) 
_______________________________ 
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declared pandemic alert stage 6 on 11 June 2009, 
indicating an ongoing influenza pandemic. India 
confirmed its first case in May 2009, and is reeling 
under the worst outbreak with over 18,000 affected 
cases and more than 1000 deaths due to H1N1 flu by 
the end of February 2015 [2].The H1N1 virus strain 
has been found to be closely related to the swine flu 
virus, but with a genetic composition that is quite 
different from the earlier known isolates. This novel 
strain is antigenically distinct from seasonal influenza 
A virus and possesses previously unrecognized 
molecular determinants that could be responsible for 
rapid human to human transmission[3].To limit 
community or hospital transmission, as well as to 
initiate antiviral therapy in time as recommended by 
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the WHO, the rapid detection of the virus in suspected 
cases remains crucial [4].Several methods are available 
to diagnose influenza virus infection including rapid 
tests for the viral antigen, immunofluorescence (IF) 
and virus RNA isolation by PCR. Real-time RT PCR is 
the latest gold standard for diagnosis of the novel 
pandemic swine 2009-H1N1 virus. Real-time RT-PCR 
assays for influenza virus using TaqMan-based probes 
have been recommended by WHO for the diagnosis of 
the currently circulating pandemic swine 2009-H1N1 
virus. In the clinical diagnosis of influenza, nucleic 
acid testing by RT-PCR has widely replaced traditional 
virus culture due to shorter turnaround times and 
increased sensitivity [5].As there are very limited 
studies in the literature depicting epidemiological 
profile of H1N1 influenza A in Indian subcontinent, the 
study aims at finding the various epidemiological 
trends, clinical profile and rapid detection of pandemic 
2009 H1N1 virus using Taqman based real time RT-
PCR assay  from respiratory specimens at a tertiary 
care hospital in northern India.  
Materials and Methods   
Nasal, nasopharyngeal and throat swabs were collected 
from 184 patients suspected of being infected with 
novel 2009 H1N1 virus from various hospitals of 
district Amritsar between the periods January 2015 to 
May 2016. Most of the clinical specimens were 
collected from patients presented with high fever 
(>38°C), running nose, sore throat and having close 
contact with laboratory confirmed case and a recent 
travel history to place with sustained human to human 
transmission of the virus. All the samples were 
transported in viral transport media and accompanied 
with duly filled proforma indicating demographic 
characteristics, clinical symptoms, co-morbidities, 
antiviral treatment, outcome, duration of stay in 
hospital etc. The samples were handled in BSL-2 
facility and were subjected to real time RT-PCR at the 
Viral research and diagnostic Laboratory, Government 
Medical College, Amritsar in accordance with the 
protocol as recommended by WHO [6]. 
RNA Extraction  
The samples were extracted using the QIAamp viral 
RNA extraction kit (Qiagen, Hilden, GERMANY) 
according to the manufacturer’s specifications. Viral 
RNA was extracted from 140 μl of clinical specimens 
and eluted in 60μl of QIAamp elution buffer. The 
eluted RNA was used immediately or stored at -80°C. 
Real-Time RT-PCR Assay 
PCR parameters of the real time RT-PCR H1N1 Panel 
were optimized using Invitrogen SuperScript III 
Platinum One-Step quantitative RT-PCR kits (Life 
Technologies, Carlsbad, USA). All real time RT-PCRs 
were performed at a total reaction volume of 25 μl. All 
primers and probes (Applied Biosystem) were provided 
by National Institute of Virology, Pune. The Influenza 
A assay was designed for universal detection of the 
matrix (M) gene of all influenza A viruses. The 
Influenza A H1N1 assay was designed to specifically 
detect the Haemagglitinin (HA) gene of influenza A 
(H1N1). The RNase P assay detects the human RNase 
P gene and is used with human clinical specimens to 
measure the quality of the specimens as well as to 
indicate that nucleic acid was extracted adequately 
from the clinical specimen.  
 
Table 1: The primer probe sequences and concentrations 
Primers and Probes                              Sequence (5’>3’)   Working Concentration 
InfA Forward GAC CRA TCC TGT CAC CTC TGA C 40 μM 
InfA Reverse AGG GCA TTY TGG ACA AAK CGT CTA 40 μM 
InfA Probe TGC AGT CCT CGC TCA CTG GGC ACG 10 μM 
InfA(H1N1) Forward GCA CGG TCA GCA CTT ATY CTR AG 40 μM 
InfA(H1N1) Reverse GTG RGC TGG GTT TTC ATT TGG TC 40 μM 
InfA(H1N1) Probe CYA CTG CAA GCC CAT ACA CAC AAG CAG GCA 10 μM 
Rnase P Forward AGA TTT GGA CCT GCG AGC G 40 μM 
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RnaseP Reverse GAG CGG CTG TCT CCA CAA GT 40 μM 
RnaseP Probe TTC TGA CCT GAA GGC TCT GCG CG 10 μM 
All analytical performance data and clinical specimen data were collected using a Step One Plus Real-Time PCR 
System (Applied Biosystems, Foster City, USA) (Figure 1)  
  
Figure 1: Amplification curve of real time RT-PCR 
(NCA: Negative Control for Influenza A; NCH: Negative Control for Influenza A(H1N1); NCRP: Negative control 
for RNase P; S1A: Sample for Influenza A ; S1H: Sample for Influenza A(H1N1); S1RP: Sample for RNase P; 
PCA: Positive Control for Influenza A ; PCH: Positive Control for Influenza A(H1N1) 
Results 
From January 2015 to May 2016, a total of 184 patients 
were tested for H1N1 influenza and seasonal influenza 
A virus. Real time PCR analysis revealed that 107 
(58.1%) samples were influenza A positive, and 48 
(26.0%) samples confirmed for H1N1 influenza. As 
our viral research and diagnostic laboratory was 
standardizing the real time PCR for influenza viruses, 
few samples were also sent to state reference 
laboratory at PGIMER, Chandigarh for the validation 
of our results. All the confirmed cases were admitted in 
the Influenza A H1N1 isolation ward at Govt.Medical 
College & Hospital, Amritsar, of which 25(52.0%) 
succumbed to the disease. Monthwise analysis of the 
cases revealed a major peak during the winter season in 
this part of India, more than 90% cases of H1N1 
influenza were detected in the months from December 
to February (Figure 2). 
 
Asian Pac. J. Health Sci., 2016; 3 (3):120-125                                          e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________
Sidhu et al                            ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2016; 3(3): 120-125 
www.apjhs.com      123 
 
 
 
Figure 2: Trend of seasonal influenza A (n=107) and Influenza A H1N1 (n=48) cases 
Age wise analysis of the positive cases revealed that 
the maximum positivity (37.5%) for H1N1 influenza 
virus belonged to the age group of 40-55 years 
followed by 20-40 years (31.2%). However seasonal 
influenza A was predominant (50.3%) in age group of 
20-40 years. Of the total patients screened 21(43.7%) 
were males and 27(56.3%) were females however no 
gender specificity of infection was observed. The 
common presenting symptoms in H1N1 positive cases 
were fever (95.8%) followed by breathlessness 
(77.0%), cough (68.7%), sore throat (56.2%), rhinitis 
(18.7%), haemoptysis(12.5%) and diarrhoea 
(4.1%)(Figure 3). Radiological findings of lungs 
showed bilateral opacities in 85.4% of cases. On 
analysis of complete haemogram it was found that 
67.3% cases had normal total leukocyte count while 
17.1% cases had neutrophilic leukocytosis and rest had 
leukemia. A total of 39 (81.2%) cases had associated 
co morbidities which included diabetes mellitus, 
hypertension, cardiovascular diseases, COPD, 
autoimmune diseases, dearranged liver or renal 
function tests. It was observed that mortality rate of 
cases who were admitted in H1N1 isolation ward was 
25(52.0%). Maximum mortality (64.0%) was found in 
the younger age group (40-60 years) , followed by 28 
% of deaths occurred in age group above 60 years. 
Most of the patients who died required intensive care 
and ventilatory support. Of the total (25) deaths, 19 
(76.0%) occurred within 48 hours of admission, of 
which 3 were within 24 hours of admission. 
 
Figure 3: Various clinical presentations among laboratory confirmed cases (n=48) of H1N1 influenza 
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Discussion 
In its strongest resurgence since the pandemic of 2009, 
the influenza type A virus known as H1N1, has broken 
out in different parts of India with deaths surpassing 
1000 mark and the number of affected cases exceeding 
18,000 by the end of February 2015 [7].The outbreak 
of the H1N1 virus is the deadliest in India since 2010. 
As many parts of the country have stopped reporting 
individual cases, particularly the milder illnesses, the 
case count is significantly lower than the number of 
cases that have occurred acually. The present study 
aims at finding the various epidemiological trends, 
clinical profile and Taqman based real time RT-PCR 
assay for rapid detection of H1N1 influenza A virus 
from respiratory specimens of suspected cases admitted 
in tertiary care hospital of northern India. Age wise 
analysis of the positive cases revealed that maximum 
positivity for H1N1 influenza belonged to the age 
group of 40-55 years (37.5%) followed by 20-40 
years(31.2%) followed by elderly patients (> 55 years), 
revealed that patients of younger age group were more 
vulnerable to H1N1 influenza A infection while the 
seasonal influenza virus seen more common in patients 
of 20-40 years. The probable reason of less infection in 
elderly population could be due to the cross preventive 
effect of antibodies developed against the circulationg 
seasonal influenza A viruses. Other studies done by 
various authors also revealed similar findings .Study 
done by Vijaydeep et al in 2012 clearly reflects the 
high prevelance, morbidity and mortality due to H1N1 
virus among younger population [8].Another study 
conducted at New Zealand concluded that H1N1 
influenza A predominantly affected young with relative 
sparing of the older population[9].According to another 
study done in Queensland, a large number of cases 
were reported in the 10-19 years age group (28%), 
followed by the 20-29 years age group (26.0%) In our 
study no gender specificity of infection was observed 
as percent infection among genders were similar.The 
most common symptoms with which patients presented 
were fever (95.8%), breathlessness(77.0%), sorethroat 
(68.7%) and cough (56.2%) (Figure 3).[10]. In a study 
done in mainland china, fever (81.0%), cough 
(40%)and sore throat (35.0%) were found to be the 
most common symptoms (Li et.al, 2009). Fever was 
also reported to be the most common (80.1%) symptom 
followed by sorethroat (61.3%) , breathlessness 
(58.3%) and cough (49.3%) in a study done by 
Domadia et al. Another study conducted at Chandigarh 
also described fever (87.2%) as the most common 
symptom followed by cough (49.7%), sorethroat (27%) 
and breathlessness (23.9%) [11].Various other authors 
in their studies done in Chile and Japan reported 
similar clinical pattern of H1N1 influenza [12].The 
clinical presentation varies from asymptomatic cases to 
primary viral pneumonia resulting in respiratory 
failure, acute respiratory distress, multiple organ failure 
and death as seen by other authors in their findings 
[13].Most but not all the  hospitalized patients had 
underlying conditions such as cardiovascular diseases, 
respiratory diseases like asthma and COPD, 
autoimmune disorders and other comorbidities include 
diabetes, hypertension etc. Our study also revealed that 
more than 60% deaths occurred in the age group 18-40 
years, with 26.3% deaths  reported in the age group of 
40-60 years and 10.5% in patients >60 years. 
Vijaydeep et al reported 57% total mortality was 
observed in patients less than 40 years of age. In the 
present study, we also demonstrated that the real time 
RT-PCR assay specifically targets the haemagglutinin 
gene of the H1N1 influenza A virus. The primers and 
probes recommended by WHO is a realiable 
identification method used for the detection of H1N1 
virus in the clinical samples taken from suspected 
patients. Unlike traditional RT-PCR, the real time RT 
PCR assay not only reduces the risk of contamination 
but also reduces turnaround time to 1-2 hours. In a 
study conducted by Kumar B and others, 48.40% of the 
samples tested positive by real time RT PCR assay 
while the traditional PCR detected only 42.46% 
thereby showing the superior sensitivity of real time 
RT PCR assay [14].In our study we detected 26.0% of 
cases found to be positive for H1N1 influenza A using 
real time RT-PCR assay.   In India, influenza virus had 
been generally ignored in public health and in 
healthcare settings. Etiology specific diagnosis requires 
laboratory tests that are not widely available in here. 
Therefore what we know about epidemiology and 
clinical features are mostly from research studies only. 
In tropical countries like India, year around circulation 
of influenza strains have been reported. In the present 
study, most of the cases of both seasonal as well as 
H1N1 influenza A virus infection peaks during the cold 
winter season (December to February). We also 
observed that co circulation of both pandemic and 
seasonal influenza during the winter season which is in 
contrast to reports from other regions in India and 
worldwide where pandemic influenza had completely 
replaced seasonal influenza strains. Mukherjee and 
associates in 2010 also reported in their study that in 
northern India with very cold winter season, peaks of 
infection was observed during winter season 
(December to Feburary) and during rainy 
season.[15,16] From the present study we have also 
seen that the prevalence of H1N1 influenza has 
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decreased, since only 8 cases were reported in year 2016 
as compared to 2015 when 40 patients were found to be 
infected with H1N1 influenza A (Figure 2). The flu season 
seems to be dying down but the war is yet not over. 
Lessons must be learnt from the previous influenza 
pandemics and it is still important to get vaccinated 
against the H1N1 flu and be prepared as activity as well as 
virulence might increase again in coming season. 
Although patients in this study comprised cases from 
Amritsar and nearby districts, the findings of this study 
need to be carefully reviewed and cannot be generalized 
to large population. We also restricted our study to one 
hospital; many cases of influenza A H1N1 admitted in our 
hospitals may have been missed. Moreover not being a 
community based study we may not be able to calculate 
the exact measures of epidemiology. There may be small 
number of cases that may have been missed out, although 
every attempt was taken to include all the cases, but this 
figure would not have been significant. This study 
provides a hospital based epidemiological information, 
but a community based wider studies are required to 
arrive at a more precise and accurate understanding of 
influenza A H1N1.Inspite of low pathogenesis, overall the 
H1N1 influenza A confirmed the ease with which 
infection can be spread and facilitated by community 
networks and gatherings. This further necessitate the need 
of active influenza surveillance and easy access to 
sensitive and rapid diagnostic methods, cheap vaccines 
and antiviral drugs in developing countries for better 
control and prevention of future pandemics. 
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